Hi Lake Charles Region:  We were contacted by Fred Bennerscheidt regarding a new drug he is marketing. Since we are unable to get together due to COVID-19, he is offering a virtual presentation to our region.

There are 3 different dates that the virtual presentation will be given. You MUST register for the event. We are hopeful that everyone will find a convenient time.

Respectfully, 

Dee Harless & Melissa Kramer

Lake Charles Co-Reps

A note from Fred:   I'd like to schedule a virtual meeting with you to discuss a newly approved LDL-C lowering treatment: NEXLETOL.1 Millions of patients with hypercholesterolemia still can’t reach their LDL-C goal, despite taking statins. Now, there’s NEXLETOL: An oral, once-daily, nonstatin therapy that can help get many of your patients with ASCVD or HeFH closer to achieving their LDL-C goal.